Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Udenafil Administration on Prefrontal Cortex Blood Flow
KCT0005833Phase 4Completed
- Sponsor
- Dong-A Pharmaceutical
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of udenafil in subcortical vascular cognitive impairment (SVCI), sponsored by Dong-A Pharmaceutical. Started Dec 2020; status: completed.
02
Drugs
udenafil
03
Conditions
subcortical vascular cognitive impairment (SVCI)
Beyond the preview
Go deeper on KCT0005833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0005833.